Mechanism of Inflammation in Age-Related Macular Degeneration by Francesco Parmeggiani, Mario R. Romano, Ciro Costagliola, Francesco Semeraro, Carlo Incorvaia, Sergio D’Angelo, Paolo Perri, Paolo De Palma, Katia De Nadai, Adolfo Sebastiani

“…Age-related macular degeneration (AMD) is a multifactorial disease that represents the most common cause of irreversible visual impairment among people over the age of 50 in Europe, the United States, and Australia, accounting for up to 50% of all cases of central blindness. …”
Get full text

Ocular Surface Temperature in Age-Related Macular Degeneration by Andrea Sodi, Sara Matteoli, Giovanni Giacomelli, Lucia Finocchio, Andrea Corvi, Ugo Menchini

“…The aim of this study is to investigate the ocular thermographic profiles in age-related macular degeneration (AMD) eyes and age-matched controls to detect possible hemodynamic abnormalities, which could be involved in the pathogenesis of the disease. …”
Get full text

Age-Related Macular Degeneration: Insights into Inflammatory Genes by Raffaella Cascella, Michele Ragazzo, Claudia Strafella, Filippo Missiroli, Paola Borgiani, Francesco Angelucci, Luigi Tonino Marsella, Andrea Cusumano, Giuseppe Novelli, Federico Ricci, Emiliano Giardina

“…Age-related macular degeneration (AMD) is a progressive neurodegenerative disease that affects approximately 8.7% of elderly people worldwide (>55 years old). …”
Get full text

Future Therapies of Wet Age-Related Macular Degeneration by Makoto Ishikawa, Daisuke Jin, Yu Sawada, Sanae Abe, Takeshi Yoshitomi

“…Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly population, and the prevalence of the disease increases exponentially with every decade after the age of 50 years. …”
Get full text

Saffron therapy for the ongoing treatment of age-related macular degeneration by Peter J McCluskey, Thomas Hong, Andrew A Chang, John Grigg, Geoffrey K Broadhead, Timothy E Schlub, Eugenia Chu

“…Objective To assess the long-term efficacy and safety of oral saffron, a natural antioxidant, in treating mild/moderate age-related macular degeneration (AMD).Methods and analysis Open-label, extension trial of 93 adults (>50 years) with mild/moderate AMD and vision >20/70 Snellen equivalent in at least 1 eye. …”
Get full text

Relationship of Retinal Vessel Caliber with Age-Related Macular Degeneration by Sara Toulouie, Sean Chang, Julia Pan, Kiersten Snyder, Glenn Yiu

“…Evaluate the relationship between retinal vascular caliber and age-related macular degeneration (AMD) severity or progression. …”
Get full text

Peroxisome Proliferator-Activated Receptor and Age-Related Macular Degeneration by Chi-Chao Chan, Jingsheng Tuo, Alexandra A. Herzlich

Get full text

Vitrectomy for full-thickness macular hole developed during aflibercept treatment for wet age-related macular degeneration by Agnieszka Nowosielska

“…A 72-year-old male, undergoing aflibercept treatment for wet age-related macular degeneration (AMD) in his left eye, developed a full-thickness macular hole after the second injection of the medication. …”
Get full text

NLRP3 Inflammasome: Activation and Regulation in Age-Related Macular Degeneration by Jiangyuan Gao, Ruozhou Tom Liu, Sijia Cao, Jing Z. Cui, Aikun Wang, Eleanor To, Joanne A. Matsubara

“…Age-related macular degeneration (AMD) is the leading cause of legal blindness in the elderly in industrialized countries. …”
Get full text

Critical Appraisal of Clinical Practice Guidelines for Age-Related Macular Degeneration by Annie M. Wu, Connie M. Wu, Benjamin K. Young, Dominic J. Wu, Curtis E. Margo, Paul B. Greenberg

“…To evaluate the methodological quality of age-related macular degeneration (AMD) clinical practice guidelines (CPGs). …”
Get full text

Identification of Key Genes and Pathways Associated with Age-Related Macular Degeneration by Junyu Zhang, Yu Zhou

“…Age-related macular degeneration (AMD) is the leading cause of severe, permanent vision loss among the elderly in the developed world. …”
Get full text

Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration by Lucas Stürzbecher, Lucas Stürzbecher, Lucas Stürzbecher, Lucas Stürzbecher, Hendrik Bartolomaeus, Hendrik Bartolomaeus, Hendrik Bartolomaeus, Hendrik Bartolomaeus, Theda U. P. Bartolomaeus, Theda U. P. Bartolomaeus, Theda U. P. Bartolomaeus, Theda U. P. Bartolomaeus, Sylvia Bolz, Andjela Sekulic, Marius Ueffing, Marius Ueffing, Simon J. Clark, Simon J. Clark, Simon J. Clark, Nadine Reichhart, Sergio Crespo-Garcia, Nicola Wilck, Nicola Wilck, Nicola Wilck, Nicola Wilck, Olaf Strauß

Subjects: “…age related macular degeneration…”
Get full text

Comparison of optical coherence tomography vs. fluorescein angiography-based macular neovascularization classifications in age-related macular degeneration by Gábor G. Deák, Klaudia Birner, Bianca S. Gerendas, Georgios Mylonas, Günther Weigert, Martin Michl, Irene Steiner, Ursula M. Schmidt-Erfurth

Get full text

OCT Biomarkers in Neovascular Age-Related Macular Degeneration: A Narrative Review by Cristian Metrangolo, Simone Donati, Marco Mazzola, Liviana Fontanel, Walter Messina, Giulia D’alterio, Marisa Rubino, Paolo Radice, Elias Premi, Claudio Azzolini

“…Age-related macular degeneration (AMD) is the leading cause of legal blindness in elderly people. …”
Get full text

Therapeutic effect of dihydroartemisinin on Alzheimer’s disease model mice with senile macular degeneration by Gao Han, Gong Xuewu, Zhang Meng, Wang Yuejing, Wang Yuchun, Zhang Keshuang, Yao Hongbo

Subjects: Get full text

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration by Ilias Zampros, Anna Praidou, Periklis Brazitikos, Panagiotis Ekonomidis, Sofia Androudi

“…Age-related macular degeneration (AMD) is the leading cause of severe visual loss and blindness over the age of 50 in developed countries. …”
Get full text

Different Strategies for the Treatment of Age-Related Macular Degeneration in China: An Economic Evaluation by Bin Wu, Jin Li, Houwen Lin, Haixiang Wu

“…To assess the cost-effectiveness of bevacizumab compared to ranibizumab, verteporfin photodynamic therapy (PDT), and usual care for the treatment of age-related macular degeneration (AMD) in China. Methods. A Markov model was developed according to patient visual acuity (VA) in the better-seeing eye (Snellen scale). …”
Get full text

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration by David R. Griffin, Preston P. Richmond, John C. Olson

Get full text

EFFICIENT RETINAL IMAGE SEGMENTATION BY U-NET FOR AGE-RELATED MACULAR DEGENERATION DIAGNOSIS by S Sujatha, Pramod Pandey, D Gnana Rajesh

Subjects: “…biomedical imaging, age-related macular degeneration, deep learning, image analysis, macular deterioration…”
Get full text

Abca4, mutated in Stargardt disease, is required for structural integrity of cone outer segments by John J. Willoughby, Abbie M. Jensen

Subjects: Get full text